International Journal of Scientific and Research Publications

Home
About Us
Editorial Board

Online Publication

Review Process
Publication Ethics

Call For Papers

Call for Research Paper

Authors

Online Submission
Paper Submission Guidelines
Online Publication Charge
Print Publication Charge
How to publish research paper
Publication Certificate
Research Catalogue
Resources
FAQs

Reviewer

Join Reviewer Panel
Reviewer Guidelines

IJSRP Publications

E-Journal
Print Journal

Downloads

IJSRP Paper Format
Instructions

Contact Us

Feedback Form
Contact Us
Site Map

IJSRP, Volume 10, Issue 9, September 2020 Edition [ISSN 2250-3153]



      M Taufik Siregar, M.Nadjib Dahlan Lubis, Delyuzar, Joko S.Lukito, Soekimin

Abstract: Prostate cancer is currently the fifth leading cause of death in men. Now immunotherapy is used as a new paradigm of prostate treatment, where the therapeutic response is aimed at the role of Tumor Infiltrating Lymphocytes (TILs). Anaplastic Lymphoma Kinase (ALK) gene fusion has found in several types of malignancies has been clinically proven to demonstrate an effective therapeutic target response for patients with positive ALK. Currently, combination therapy continues to be developed, especially in cases of recurrence and metastasis, so it is necessary to research on prostate adenocarcinoma.

[Reference this Paper]   [BACK]

Ooops! It appears you don't have a PDF plugin for this barrPostingser. you can click here to download the PDF file.

Reference this Research Paper (copy & paste below code):

M Taufik Siregar, M.Nadjib Dahlan Lubis, Delyuzar, Joko S.Lukito, Soekimin (2020); The Correlation Of Immunochemistry Expression Anaplastic Lymphoma Kinase (ALK) With Level Of Stromal Tumor Infiltrating Lymphocytes (STILS) In Prostate Adenocarcinoma; International Journal of Scientific and Research Publications (IJSRP) 10(09) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.10.09.2020.p10584

IJSRP PUBLICATIONS

Home

About Us
Editorial Board
Call for Paper

Call for Research Paper
Paper Status
IJSRP Paper Format
Join Us

Download e-journal
Join Forum
Invite Friends
Subscribe
Get Social with Us!



Copyright © 2011-2021, IJSRP Inc., All rights reserved.